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The survival of pathogenic mycobacteria in macrophages requires the eukaryotic enzyme-like serine/threo-
nine protein kinase G. This kinase with unknown specificity is secreted into the cytosol of infected macrophages
and inhibits phagosome-lysosome fusion. The pknG gene is the terminal gene in a putative operon containing
glnH, encoding a protein potentially involved in glutamine uptake. Here, we report that the deletion of pknG
did not affect either glutamine uptake or intracellular glutamine concentrations. In vitro growth of Mycobac-
terium bovis BCG lacking pknG was identical to that of the wild type. We conclude that in M. bovis BCG,
glutamine metabolism is not regulated by protein kinase G.
The resistance of pathogenic mycobacteria to host innate
immune responses has been attributed to their ability to block
phagosome-lysosome fusion. This results in their capability to
persist inside macrophages, avoiding bactericidal activities of
the host macrophages (9, 15, 16). The genome of Mycobacte-
rium tuberculosis encodes 11 eukaryotic enzyme-like serine/
threonine protein kinases (1, 7). Among these, protein kinase
G (PknG) was recently found to promote mycobacterial sur-
vival in macrophages. Although a role for PknG in mycobac-
terial physiology remains to be established, PknG blocks pha-
gosome-lysosome fusion in infected macrophages where it is
secreted into the cytosol. Disruption of the pknG gene in
Mycobacterium bovis BCG by homologous recombination, as
well as chemical inhibition of PknG by a specific inhibitor,
leads to accelerated phagosome maturation and a growth de-
fect in macrophages (19). The pknG gene is the last gene in a
putative operon that includes Rv0412c (encoding an unknown
membrane protein) and glnH (Fig. 1A) in all mycobacterial
genomes sequenced. The glnH gene is predicted to encode a
glutamine-binding lipoprotein that might be involved in glu-
tamine import through the membrane (1, 6). In Escherichia coli
and Bacillus subtilis, glnH is located in the glutamine permease
operon including glnP and glnQ, which together form an ABC
transporter. This operon is essential for glutamine import ac-
tivity (13). In the M. tuberculosis genome, the putative glu-
tamine importing system consists of five proteins encoded by
genes locating in three different regions (GlnH, Rv2563 and
GlnQ, and Rv0072 and Rv0073). GlnQ and Rv0073 are ho-
mologous to nucleotide binding proteins, while Rv2563 and
Rv0072 are membrane-spanning proteins. These two pairs of
proteins are expected to form one or two separate glutamine
transporters, while glnH is thought to encode the substrate
binding protein (4).
Glutamine biosynthesis is catalyzed by glutamine synthase,
which ligates the ammonium group to L-glutamate. The dele-
tion of glutamine synthase in M. tuberculosis resulted in L-
glutamine auxotrophicity and attenuated growth in human
THP-1 macrophages (18). In addition, the glutamine synthase-
negative mutant is avirulent in the highly susceptible guinea pig
model of pulmonary tuberculosis (18). Depletion of glutamine
synthase activity by a specific inhibitor (11) or antisense tech-
nology (12) has been shown to effectively inhibit growth of M.
tuberculosis.
Given the importance of glutamine metabolism for myco-
bacterial survival and the possible location of pknG and glnH
within the same operon, we analyzed the roles of PknG in
glutamine metabolism and growth of M. bovis BCG.
Transcription of glnH and ackA in the presence or absence
of pknG. To analyze possible coregulation of the genes located
surrounding pknG, transcription of glnH (forward primer, 5-
TCGGGATCAACCTGGACAA-3; reverse primer, 5-GAG
CACCGTCAGCCACTTG-3), ackA encoding an acetate ki-
nase (forward primer, 5-GGGCGTCATCAGCTACTTGTG-
3; reverse primer, 5-CCGCCAACCCCAACATC-3), and
pknG (forward primer, 5-GCCACCGACATCTACACCGT-
3; reverse primer, 5-GGTGTGCGCCACCAGCAG-3) was
measured by RT-PCR. As a control, transcription of the 16S
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TABLE 1. Free glutamine/glutamate levels in M. bovis BCG and
M. bovis BCG-pknG grown in Proskauer-Beck medium
Amino acid
Amino acid level (pmol) (mean  SD) of
indicated M. bovis strain
BCG BCG-pknG
Glutamine 5.77  0.24 6.1  0.21
Glutamate 36.57  1.11 40.20  1.17
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FIG. 1. (A) Genomic organization at the pknG locus. (B) RT-PCR analysis for expression of genes ackA, glnH, and pknG predicted to share
the same operon. Expression of 16S rRNA genes was used as a control.
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rRNA gene (forward primer, 5-ACGAACAACGCGACAAA
CC-3; reverse primer, 5-CCAGCAGCCGCGGTAA-3) was
also analyzed. RNA samples were isolated from wild-type M.
bovis BCG and M. bovis BCG pknG (BCG-pknG) (19) by
using the RNeasy midi kit (QIAGEN Inc., Valencia, CA) and
treated with DNase for 3 h at 37°C. To analyze transcription,
cDNA was synthesized from 1 g of total RNA by using Su-
perscript III (Invitrogen Life Technologies, Carlsbad, CA) and
random primers (Promega Inc., Madison, WI), followed by
amplification of the products by using gene-specific primers
(see above).
No pknG transcript was detected in M. bovis BCG-pknG,
whereas transcription of glnH and ackA was not effected in the
pknG mutant (Fig. 1B), suggesting that PknG does not con-
trol the transcription of glnH and ackA. In addition, this result
excludes the possibility that the deletion of pknG by homolo-
gous recombination in the pknG mutant resulted in impaired
expression of glnH and ackA.
Effect of PknG depletion on in vitro growth. Changes in
glutamine metabolism have been reported to alter the in vitro
growth characteristics of mycobacteria (12, 18). To analyze a
contribution of PknG to the in vitro growth of M. bovis BCG,
wild-type M. bovis BCG, and M. bovis BCG-pknG (strain
Montreal) were grown in 7H9-OADC medium as well as in
two different defined media, Sauton and Proskauer-Beck (PB)
media, whose nitrogen sources were based on asparagines,
supplemented with 0.05% Tween 80 (14). The in vitro growth
of M. bovis BCG-pknG and the growth of its parental strain
were monitored by measuring the optical densities of liquid
cultures at a wavelength of 600 nm (OD600). Saturated cul-
tures (OD600 of 1.5) stored at 70°C were used to inoculate
fresh media to the final OD600 of 0.1, and cultures were
incubated at 37°C with orbital shaking. In none of the media
tested was there any detectable alteration in the growth of
M. bovis BCG-pknG compared to that of its parental strain
(Fig. 2).
Effect of PknG depletion on glutamine uptake. As glnH, the
gene adjacent to pknG, has been suggested to be part of a
glutamine transport system (4, 7, 8) and glnH and pknG may be
part of the same operon, the contribution of PknG to glu-
tamine transport was investigated. To that end, the uptake of
[3H]glutamine (Amersham) by M. bovis BCG or M. bovis
BCG-pknG grown in 7H9-OADC, PB, and Sauton media
supplemented with 0.05% Tween 80 was analyzed. Bacterial
cultures growing at exponential phase (OD600 of 0.5) were
washed and diluted to an OD600 of 0.2 with fresh medium.
Diluted cultures were then distributed in 96-well plates (in
triplicate) and incubated for 2 h at 37°C before the addition of
1 Ci [3H]glutamine to each well (final concentration of
[3H]glutamine, 0.1 M). After incubation times, cultures from
FIG. 2. In vitro growth of M. bovis BCG () and M. bovis BCG-pknG (f) in 7H9-OADC, Sauton, and PB media. The expression levels of
PknG in the different strains were analyzed at day 6 by immunoblotting of lysates separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis followed by immunoblotting (inset).
FIG. 3. Effects of PknG depletion on uptake of glutamine. Uptake of [3H]glutamine by M. bovis BCG () and M. bovis BCG-pknG (f) in
7H9-OADC, Sauton, and PB media.
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plates were harvested to UniFilter plates (Packard) and
washed to remove extracellular glutamine. Cell-incorporated
radioactivity was counted by using the Topcount microplate
scintillation counter (Packard). As shown in Fig. 3, no glu-
tamine uptake activity was observed for the bacteria grown in
PB and Sauton media. As expected, glutamine was readily
internalized by strains grown in 7H9-OADC, reflecting the
accelerated extracellular glutamine synthesis and transport
when mycobacteria are grown in 7H9, which is supplemented
with L-glutamate, the direct substrate of extracellular glu-
tamine synthase (10). However, glutamine uptake was identical
in M. bovis BCG lacking pknG (Fig. 3), indicating that PknG
does not contribute to glutamine uptake.
Effect of PknG depletion on intracellular glutamine concen-
tration. An impaired uptake of glutamine would affect the
intracellular level of glutamine and other amino acids. To
analyze intracellular glutamine levels, M. bovis BCG and M.
bovis BCG-pknG were grown in the different media indicated
in Fig. 4 and homogenized, and aliquots equalized for similar
protein amounts (bicinchoninic acid; Pierce) were analyzed
spectrophotometrically for the presence of glutamine via en-
zymatic deamination by glutaminase (Sigma). M. bovis BCG
and M. bovis BCG-pknG grown in the different media indi-
cated in Fig. 3 displayed equal levels of glutamine. To obtain
an independent assessment of the levels of glutamine in wild-
type M. bovis BCG and M. bovis BCG-pknG, homogenates
were either analyzed directly (Tables 1 and 2) or after hydro-
lysis (Table 3), followed by concentration and phenylisothio-
cyanate derivatization of the amino acids as described previ-
ously (2, 3, 5). The levels of the amino acids measured were
similar between wild-type and pknG mutant bacteria (ex-
pressed as percentages of total amino acids determined [Ta-
bles 1 and 2]). Importantly, no difference in the levels of glu-
tamine and glutamate was observed, indicating that in M. bovis
BCG, glutamine does not accumulate upon pknG deletion.
Concluding remarks. The availability of glutamine for myco-
bacteria has been suggested to be crucial for growth and survival
both in vitro and within macrophages (18). The positioning of a
gene encoding a putative glutamine binding protein, glnH, adja-
cent to pknG, has led to the suggestion that in M. tuberculosis, one
function of PknG is associated with glutamine metabolism (1, 8).
While PknG may perform an as yet unknown function in myco-
bacterial physiology, the results presented here show that the
depletion of PknG in M. bovis BCG has no effect on in vitro
growth. In addition, there was no detectable defect in glutamine
uptake or altered intracellular concentration observed in our ex-
periments, suggesting that modulation of glutamine metabolism
does not contribute to the intracellular degradation of M. bovis
BCG lacking PknG (19).
There have been examples suggesting variations in gene
functions and pathogenesis among M. tuberculosis, M. bovis,
and M. bovis BCG (17). The molecular basis for different roles
described for PknG in these bacteria needs to be further char-
acterized.
FIG. 4. Glutamine levels in lysates of M. bovis BCG and M. bovis BCG-pknG as measured via enzymatic deamination by glutaminase.
TABLE 2. Free glutamine/glutamate levels in M. bovis BCG and
M. bovis BCG-pknGgrown in Sauton medium
Amino acid
Amino acid level (pmol) (mean  SD) of
indicated M. bovis strain
BCG BCG-pknG
Glutamine 0.85  0.09 0.64  0.10
Glutamate 28.11  2.81 29.12  2.00
TABLE 3. Total glutamine levels in M. bovis BCG and M. bovis
BCG-pknG grown in Sauton and Proskaur-Beck media
Medium
Glutamine level (pmol) (mean  SD) of
indicated M. bovis strain
BCG BCG-pknG
Proskaur-Beck 20.73  0.19 20.00  0.13
Sauton 11.28  0.15 11.20  0.41
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